After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases
Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol.
Gespeichert in:
| Veröffentlicht in: | Reumatologia clinica 2019-09, Vol.15 (5), p.e33-e35 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e35 |
|---|---|
| container_issue | 5 |
| container_start_page | e33 |
| container_title | Reumatologia clinica |
| container_volume | 15 |
| creator | Mateos Rodríguez, Javier José Bellido, David Castro, David Portillo Sánchez, José Vanegas, Raúl Núñez García, Alicia |
| description | Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol. |
| doi_str_mv | 10.1016/j.reuma.2017.04.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1903159840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1903159840</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-c585c1d064f02f510c0f050cdd578c3f44e694a31b0141b6f7e0c66ddc150bc73</originalsourceid><addsrcrecordid>eNo1kE1LxDAYhIMg7rLuLxAkRw-2vm-bpK23svgFC170XNJ8sJG2qUmr7r-34HoYZg4PAzOEXCGkCCjuPtJg5l6mGWCRAksB4YyssSx5gnlVrsg2RtcCViIrBBQXZJWVnAmEbE2a2k4mUCtdNwdDv910oFKZwSu_VAbf3dLgvpbwI1s5UDdQOUxuPPi4qHOj0zQeBx18b-5pTYMZfZiotzSjSkYTL8m5lV0025NvyPvjw9vuOdm_Pr3s6n0yZohTonjJFWoQzEJmOYICCxyU1rwoVW4ZM6JiMsdlBsNW2MKAEkJrhRxaVeQbcvPXOwb_OZs4Nb2LynSdHIyfY4MV5MirksGCXp_Que2NbsbglqXH5v-U_BdfH2TJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1903159840</pqid></control><display><type>article</type><title>After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Mateos Rodríguez, Javier José ; Bellido, David ; Castro, David ; Portillo Sánchez, José ; Vanegas, Raúl ; Núñez García, Alicia</creator><creatorcontrib>Mateos Rodríguez, Javier José ; Bellido, David ; Castro, David ; Portillo Sánchez, José ; Vanegas, Raúl ; Núñez García, Alicia</creatorcontrib><description>Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol.</description><identifier>EISSN: 1885-1398</identifier><identifier>EISSN: 2173-5743</identifier><identifier>DOI: 10.1016/j.reuma.2017.04.010</identifier><identifier>PMID: 28546102</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Acenocoumarol - therapeutic use ; Adult ; Anticoagulants - therapeutic use ; Antiphospholipid Syndrome - drug therapy ; Carotid Artery Thrombosis - diagnostic imaging ; Factor Xa Inhibitors - therapeutic use ; Humans ; International Normalized Ratio ; Male ; Rivaroxaban - therapeutic use ; Treatment Outcome ; Venous Thromboembolism - drug therapy</subject><ispartof>Reumatologia clinica, 2019-09, Vol.15 (5), p.e33-e35</ispartof><rights>Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28546102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mateos Rodríguez, Javier José</creatorcontrib><creatorcontrib>Bellido, David</creatorcontrib><creatorcontrib>Castro, David</creatorcontrib><creatorcontrib>Portillo Sánchez, José</creatorcontrib><creatorcontrib>Vanegas, Raúl</creatorcontrib><creatorcontrib>Núñez García, Alicia</creatorcontrib><title>After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases</title><title>Reumatologia clinica</title><addtitle>Reumatol Clin</addtitle><description>Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol.</description><subject>Acenocoumarol - therapeutic use</subject><subject>Adult</subject><subject>Anticoagulants - therapeutic use</subject><subject>Antiphospholipid Syndrome - drug therapy</subject><subject>Carotid Artery Thrombosis - diagnostic imaging</subject><subject>Factor Xa Inhibitors - therapeutic use</subject><subject>Humans</subject><subject>International Normalized Ratio</subject><subject>Male</subject><subject>Rivaroxaban - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Venous Thromboembolism - drug therapy</subject><issn>1885-1398</issn><issn>2173-5743</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LxDAYhIMg7rLuLxAkRw-2vm-bpK23svgFC170XNJ8sJG2qUmr7r-34HoYZg4PAzOEXCGkCCjuPtJg5l6mGWCRAksB4YyssSx5gnlVrsg2RtcCViIrBBQXZJWVnAmEbE2a2k4mUCtdNwdDv910oFKZwSu_VAbf3dLgvpbwI1s5UDdQOUxuPPi4qHOj0zQeBx18b-5pTYMZfZiotzSjSkYTL8m5lV0025NvyPvjw9vuOdm_Pr3s6n0yZohTonjJFWoQzEJmOYICCxyU1rwoVW4ZM6JiMsdlBsNW2MKAEkJrhRxaVeQbcvPXOwb_OZs4Nb2LynSdHIyfY4MV5MirksGCXp_Que2NbsbglqXH5v-U_BdfH2TJ</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Mateos Rodríguez, Javier José</creator><creator>Bellido, David</creator><creator>Castro, David</creator><creator>Portillo Sánchez, José</creator><creator>Vanegas, Raúl</creator><creator>Núñez García, Alicia</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201909</creationdate><title>After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases</title><author>Mateos Rodríguez, Javier José ; Bellido, David ; Castro, David ; Portillo Sánchez, José ; Vanegas, Raúl ; Núñez García, Alicia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-c585c1d064f02f510c0f050cdd578c3f44e694a31b0141b6f7e0c66ddc150bc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2019</creationdate><topic>Acenocoumarol - therapeutic use</topic><topic>Adult</topic><topic>Anticoagulants - therapeutic use</topic><topic>Antiphospholipid Syndrome - drug therapy</topic><topic>Carotid Artery Thrombosis - diagnostic imaging</topic><topic>Factor Xa Inhibitors - therapeutic use</topic><topic>Humans</topic><topic>International Normalized Ratio</topic><topic>Male</topic><topic>Rivaroxaban - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Venous Thromboembolism - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mateos Rodríguez, Javier José</creatorcontrib><creatorcontrib>Bellido, David</creatorcontrib><creatorcontrib>Castro, David</creatorcontrib><creatorcontrib>Portillo Sánchez, José</creatorcontrib><creatorcontrib>Vanegas, Raúl</creatorcontrib><creatorcontrib>Núñez García, Alicia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Reumatologia clinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mateos Rodríguez, Javier José</au><au>Bellido, David</au><au>Castro, David</au><au>Portillo Sánchez, José</au><au>Vanegas, Raúl</au><au>Núñez García, Alicia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases</atitle><jtitle>Reumatologia clinica</jtitle><addtitle>Reumatol Clin</addtitle><date>2019-09</date><risdate>2019</risdate><volume>15</volume><issue>5</issue><spage>e33</spage><epage>e35</epage><pages>e33-e35</pages><eissn>1885-1398</eissn><eissn>2173-5743</eissn><abstract>Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol.</abstract><cop>Spain</cop><pmid>28546102</pmid><doi>10.1016/j.reuma.2017.04.010</doi></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1885-1398 |
| ispartof | Reumatologia clinica, 2019-09, Vol.15 (5), p.e33-e35 |
| issn | 1885-1398 2173-5743 |
| language | eng ; spa |
| recordid | cdi_proquest_miscellaneous_1903159840 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Acenocoumarol - therapeutic use Adult Anticoagulants - therapeutic use Antiphospholipid Syndrome - drug therapy Carotid Artery Thrombosis - diagnostic imaging Factor Xa Inhibitors - therapeutic use Humans International Normalized Ratio Male Rivaroxaban - therapeutic use Treatment Outcome Venous Thromboembolism - drug therapy |
| title | After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A45%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=After%20failure%20with%20acenocoumarol,%20rivaroxaban%20in%20antiphospholipid%20syndrome:%20A%20report%20of%202%20cases&rft.jtitle=Reumatologia%20clinica&rft.au=Mateos%20Rodr%C3%ADguez,%20Javier%20Jos%C3%A9&rft.date=2019-09&rft.volume=15&rft.issue=5&rft.spage=e33&rft.epage=e35&rft.pages=e33-e35&rft.eissn=1885-1398&rft_id=info:doi/10.1016/j.reuma.2017.04.010&rft_dat=%3Cproquest_pubme%3E1903159840%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1903159840&rft_id=info:pmid/28546102&rfr_iscdi=true |